These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18753628)

  • 1. Gastrin-releasing peptide receptor silencing suppresses the tumorigenesis and metastatic potential of neuroblastoma.
    Qiao J; Kang J; Ishola TA; Rychahou PG; Evers BM; Chung DH
    Proc Natl Acad Sci U S A; 2008 Sep; 105(35):12891-6. PubMed ID: 18753628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphatidylinositol 3-kinase regulation of gastrin-releasing peptide-induced cell cycle progression in neuroblastoma cells.
    Ishola TA; Kang J; Qiao J; Evers BM; Chung DH
    Biochim Biophys Acta; 2007 Jun; 1770(6):927-32. PubMed ID: 17379415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FAK is a critical regulator of neuroblastoma liver metastasis.
    Lee S; Qiao J; Paul P; O'Connor KL; Evers MB; Chung DH
    Oncotarget; 2012 Dec; 3(12):1576-87. PubMed ID: 23211542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting gastrin-releasing peptide suppresses neuroblastoma progression via upregulation of PTEN signaling.
    Paul P; Qiao J; Kim KW; Romain C; Lee S; Volny N; Mobley B; Correa H; Chung DH
    PLoS One; 2013; 8(9):e72570. PubMed ID: 24039782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrin-releasing peptide-induced down-regulation of tumor suppressor protein PTEN (phosphatase and tensin homolog deleted on chromosome ten) in neuroblastomas.
    Qiao J; Kang J; Cree J; Evers BM; Chung DH
    Ann Surg; 2005 May; 241(5):684-91; discussion 691-2. PubMed ID: 15849504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Akt2 regulates metastatic potential in neuroblastoma.
    Qiao J; Lee S; Paul P; Qiao L; Taylor CJ; Schlegel C; Colon NC; Chung DH
    PLoS One; 2013; 8(2):e56382. PubMed ID: 23468863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential regulation of cyclin-dependent kinase inhibitors in neuroblastoma cells.
    Qiao L; Paul P; Lee S; Qiao J; Wang Y; Chung DH
    Biochem Biophys Res Commun; 2013 May; 435(2):295-9. PubMed ID: 23618860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Silencing gastrin-releasing peptide receptor suppresses key regulators of aerobic glycolysis in neuroblastoma cells.
    Rellinger EJ; Romain C; Choi S; Qiao J; Chung DH
    Pediatr Blood Cancer; 2015 Apr; 62(4):581-6. PubMed ID: 25630799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrin-releasing peptide is a growth factor for human neuroblastomas.
    Kim S; Hu W; Kelly DR; Hellmich MR; Evers BM; Chung DH
    Ann Surg; 2002 May; 235(5):621-9; discussion 629-30. PubMed ID: 11981207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bombesin induces angiogenesis and neuroblastoma growth.
    Kang J; Ishola TA; Baregamian N; Mourot JM; Rychahou PG; Evers BM; Chung DH
    Cancer Lett; 2007 Aug; 253(2):273-81. PubMed ID: 17383815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced autophagy blocks angiogenesis via degradation of gastrin-releasing peptide in neuroblastoma cells.
    Kim KW; Paul P; Qiao J; Lee S; Chung DH
    Autophagy; 2013 Oct; 9(10):1579-90. PubMed ID: 24108003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ets1 transcription factor mediates gastrin-releasing peptide-induced IL-8 regulation in neuroblastoma cells.
    Qiao J; Kang JH; Cree J; Evers BM; Chung DH
    Neoplasia; 2007 Mar; 9(3):184-91. PubMed ID: 17401458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrin-releasing peptide activates Akt through the epidermal growth factor receptor pathway and abrogates the effect of gefitinib.
    Liu X; Carlisle DL; Swick MC; Gaither-Davis A; Grandis JR; Siegfried JM
    Exp Cell Res; 2007 Apr; 313(7):1361-72. PubMed ID: 17349623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting gastrin-releasing peptide as a new approach to treat aggressive refractory neuroblastomas.
    Paul P; Gillory LA; Kang J; Qiao J; Chung DH
    Surgery; 2011 Mar; 149(3):425-32. PubMed ID: 21035156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrin β1 is critical for gastrin-releasing peptide receptor-mediated neuroblastoma cell migration and invasion.
    Lee S; Qiao J; Paul P; Chung DH
    Surgery; 2013 Aug; 154(2):369-75. PubMed ID: 23889963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-335 and miR-363 regulation of neuroblastoma tumorigenesis and metastasis.
    Qiao J; Lee S; Paul P; Theiss L; Tiao J; Qiao L; Kong A; Chung DH
    Surgery; 2013 Aug; 154(2):226-33. PubMed ID: 23806264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastrin-releasing peptide and its receptor increase arthritis fibroblast-like synoviocytes invasiveness through activating the PI3K/AKT pathway.
    Clarimundo VS; Farinon M; Pedó RT; Teixeira VON; Nör C; Gulko PS; Xavier RM; de Oliveira PG
    Peptides; 2017 Sep; 95():57-61. PubMed ID: 28733141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-GRP-R monoclonal antibody antitumor therapy against neuroblastoma.
    Qiao J; Liu J; Jacobson JC; Clark RA; Lee S; Liu L; An Z; Zhang N; Chung DH
    PLoS One; 2022; 17(12):e0277956. PubMed ID: 36525420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2.
    Li D; Mei H; Pu J; Xiang X; Zhao X; Qu H; Huang K; Zheng L; Tong Q
    Mol Cancer; 2015 Feb; 14():47. PubMed ID: 25889839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth inhibition of non-small-cell lung carcinoma by BN/GRP antagonist is linked with suppression of K-Ras, COX-2, and pAkt.
    Hohla F; Schally AV; Kanashiro CA; Buchholz S; Baker B; Kannadka C; Moder A; Aigner E; Datz C; Halmos G
    Proc Natl Acad Sci U S A; 2007 Nov; 104(47):18671-6. PubMed ID: 18003891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.